Tag: cocp

Commercial & Investment Banking Picture Gallery

Cocrystal Announces Positive Data from the Successful Completion of Phase 1a/1b Trial of the Non-Nucleoside Polymerase Inhibitor CC-31244 for the Treatment of Chronic Hepatitis C Infection

August 15, 2017
Presse

ATLANTA, GA and BOTHELL, WA -- (Marketwired) -- 08/15/17 -- Cocrystal Pharma, Inc. (OTCQB: COCP), a…

Continue Reading
Commercial & Investment Banking Picture Gallery

Cocrystal Pharma Receives Investment Through Private Placement

April 24, 2017
Presse

BOTHELL, WA and ATLANTA, GA -- (Marketwired) -- 04/24/17 -- On April 20, 2017, Cocrystal Pharma,…

Continue Reading